Old drug, new hope: lithium tested to stop Alzheimer's before it starts
NCT ID NCT03185208
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tested whether lithium, a drug used for mood disorders, can prevent Alzheimer's dementia in older adults with mild cognitive impairment (MCI). 83 participants took either lithium or a placebo for a period, and researchers measured memory, thinking skills, and brain changes. The goal was to see if lithium could slow or stop the progression to dementia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lithium Carbonate
- What this could lead to
- If successful, this could point toward a way to slow or prevent Alzheimer's dementia in people with early memory problems.
- What could go wrong
- This is a small, completed phase 4 trial. Lithium has side effects and may not show clear benefits. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your brain help unlock Alzheimer's secrets?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Refresher training may extend brain benefits for veterans with mild memory issues
- Brain training may sharpen aging minds in diabetes
- Could the immune system hold clues to brain diseases?
- Brain waves in headphones: a simple sound trick to sharpen aging minds?